Xolair (Omalizumab)
Brand: Xolair
Active Ingredient(s): Omalizumab
Strength: 75 mg – 150 mg
Pack Size: 1 unit – 1 unit Prefilled Syringe
Store in the refrigerator.
DIN: 02459787 – 02459795
Manufacturer: Novartis Pharma Canada Inc. (Canada)
Alternatives:
*A valid prescription is required for Rx items.
Description
Xolair (Omalizumab) is an anti-asthmatic agent. It is usually used to treat moderate to severe asthma (a disease that affects your lungs) that is caused by allergies by adults and children who are at least 6 years old, whose symptoms are inadequately controlled with inhaled corticosteroids. It is also used to treat chronic idiopathic urticaria (a disturbing allergic condition of the skin). It may also have other uses.
Additional information
Xolair (Omalizumab)'s dosage depends on the condition being treated. Your doctor or pharmacist may have suggested a schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist. Administer Xolair by subcutaneous (under the skin) injection. Xolair is intended for use under the guidance of a healthcare provider. Initiate therapy in a healthcare setting and once therapy has been safely established, the healthcare provider may determine whether self-administration of Xolair Prefilled Syringe is appropriate, based on careful assessment of risk for anaphylaxis (a severe, potentially life-threatening allergic reaction). WARNING: XOLAIR is not used to treat sudden breathing problems. Use with caution in patients at high risk for parasitic infections (an infectious disease caused or transmitted by a parasite). In addition to its desired action, Xolair (Omalizumab) may cause some side effects, notably: It may cause injection site reaction, headache, viral infections. It may cause alopecia (hair loss), dermatitis (skin irritation), pruritus (severe itching of the skin). It may cause upper respiratory tract infections, urinary tract infection, sinusitis (inflammation of a nasal sinus). Contraindications: Severe hypersensitivity reaction to omalizumab or any component of the formulation. Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Xolair (Omalizumab) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Xolair (Omalizumab)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews